Tag: Transcend Therapeutics
Skadden advises Otsuka on potential USD1.2bn biotech buy
Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company
Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company
Follow us on LinkedIn